This vaccine obtained favorable and safe results, including the production of high affinity anti-tau antibodies in most patients, reduction of blood neurofilament and p-tau in CSF, and a slowing of cognitive decline in younger patients [109]. Here, MAPT is linked to Mental deterioration.